COVID-19 Offerings

Syngene provides a range of services in the areas of diagnostics as well as therapeutic and vaccine R&D.


Syngene has an excellent track record in expression and purification of protein reagents and antibodies from various expression systems – bacterial, mammalian, insect cells, and yeast. We make and ship more than 2000 proteins a year to our clients.

Primers and Probes

Syngene produces SARS-CoV-2 specific, primers and probes. We provide custom oligos defined by our customers, as well as those mentioned in protocols recommended by WHO, CDC and ICMR.

Vaccine R&D

Syngene collaborates and provides technical assistance to vaccine manufacturers for their virosome technology-based COVID-19 vaccine development. As part of the collaboration, Syngene will  run animal immunization studies to validate the specific immune response to potentially create antibodies.